• SIGN IN
  • GET HELP
  •  

    Webinar Details


    Event Type

    Live Online

    Date

    Friday, December 2, 2022

    Time

    2:00 PM - 3:00 PM ET

    Location

    PharmCon Webinar Studio (freeCE.com)

    Credits

    1 Contact Hour(s)

    Target Audience

    Pharmacist, Pharmacy Technician, Nurse

    Cost

    $30.00

    • Overview

      Maintaining compliance with federal controlled substances laws and regulations is paramount for pharmacists. These laws exist to protect the public by preventing misuse, abuse, and diversion of controlled substances. Additionally, the penalties for noncompliance can be drastic for pharmacists. The Drug Enforcement Administration has recently issued several proposed and final regulations which will have several implications for pharmacy practice. Additionally, the Department of Health and Human Services updated eligibility requirements to prescribe buprenorphine products for Opioid Use Disorder. This knowledge-based program will provide updates on the federal regulation of controlled substances for the practicing pharmacist.


      Handouts

      Slide Document 21316L03_2pp.pdf
      Slide Document 21316L03_6pp.pdf





      Financial Support By

      PharmCon
    • Pharmacist

      Recognize recent proposed and final regulations from the Drug Enforcement Administration
      Identify updates to the DEA’s 2020 Pharmacist’s Manual
      Determine requirements for health care practitioners to prescribe buprenorphine products for Opioid Use Disorder

      Pharmacy Technician

      Recognize recent proposed and final regulations from the Drug Enforcement Administration
      Identify updates to the DEA’s 2020 Pharmacist’s Manual
      Determine requirements for health care practitioners to prescribe buprenorphine products for Opioid Use Disorder

      Nurse

      Recognize recent proposed and final regulations from the Drug Enforcement Administration
      Identify updates to the DEA’s 2020 Pharmacist’s Manual
      Determine requirements for health care practitioners to prescribe buprenorphine products for Opioid Use Disorder
    • Repeat Presentation

      This presentation was last given on 12/22/2022 9:00 PM

      Future Airings

      Date Time
      Thursday, December 22, 2022 9:00 PM View

    • Activity Type

      Knowledge

      CE Broker

      20-891450

      Universal Activity Number

      Pharmacist 0798-0000-21-316-L03-P

      Pharmacy Technician 0798-0000-21-316-L03-T

      Nurse 0798-0000-21-316-L03-N

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, attendees must respond to all randomly-generated participation checks and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.


    HARDWARE REQUIREMENTS
    Windows 8.1
    Windows 10
    Apple Mac OS X 10.13 or higher
    iOS 10+
    Android 4.3+


    SOFTWARE REQUIREMENTS
    Google Chrome
    Mozilla Firefox

    Log in locally; do not log in using a VPN, cloud server, remote desktop, etc.


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     

    This continuing education activity is held as copyright by PharmCon. Through this notice, PharmCon. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).




    Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.